UTEK subsidiary acquired by Advanced Refractive Technologies

By Lisa Kerner

Erie, Pa., April 11 - Advanced Glaucoma Technologies, Inc., a subsidiary of UTEK Corp., was acquired by Advanced Refractive Technologies, Inc. in a tax-free stock-for-stock exchange according to a form 8-K filed with the Securities and Exchange Commission by UTEK.

Advanced Refractive issued 100,000 unregistered shares of series D convertible preferred stock to UTEK in exchange for the outstanding shares of Advanced Glaucoma on April 4.

Advanced Glaucoma holds the exclusive license to a patent-pending non-surgical treatment for reducing pressure build up in the eye using specific monoclonal antibodies.

UTEK is a technology transfer company based in Plant City, Fla.

Advanced Refractory Technologies is a supplier of advanced ceramic materials located in Buffalo, N.Y.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.